Effect of host immunity on metastatic potential in renal cell carcinoma: The assessment of optimal in vivo models to study metastatic behavior of renal cancer cells

Tumor Biology

Volumn 33, Issue 2, 2012, Pages 551-559

  Kobayashi, Minoru ^a   Morita, Tatsuo ^a   Chun, Nicole A L ^a   Matsui, Aya ^b   Takahashi, Masafumi ^b   Murakami, Takashi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Bioluminescent imaging; Host immunity; Intracardiac injection; Metastasis; Rat renal cancer; Syngeneic animal model

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CARCINOMA CELL; CONTROLLED STUDY; HOST IMMUNITY; HUMAN; HUMAN CELL; IMMUNITY; IN VIVO STUDY; KIDNEY CARCINOMA; LUNG METASTASIS; MALE; METASTASIS POTENTIAL; MONITORING; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; RAT; SCID MOUSE; ANIMAL; DISEASE MODEL; IMMUNE SYSTEM; IMMUNOLOGY; KIDNEY TUMOR; METABOLISM; METASTASIS; MOUSE MUTANT; NEOPLASM; PATHOLOGY; SPECIES DIFFERENCE; TIME; TUMOR CELL LINE;

ANIMALS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM; KIDNEY NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; RATS; SPECIES SPECIFICITY; TIME FACTORS;

EID: 84860263518     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0300-4     Document Type: Article

References (21)

1. Flanigan RC, Campbell SC, Clark JI, Picken MM. Metastatic renal cell carcinoma. Curr Treat Options Oncol. 2003;4:385-90.
2. Kim M, Yan Y, Lee K, Sgagias M, Cowan KH. Ectopic expression of von Hippel-Lindau tumor suppressor induces apoptosis in 786- O renal cell carcinoma cells and regresses tumor growth of 786-O cells in nude mouse. Biochem Biophys Res Commun. 2004;320:945-50.
3. Yu K, Lucas J, Zhu T, Zask A, Gaydos C, Toral-Barza L, Gu J, Li F, Chaudhary I, Cai P, Lotvin J, Petersen R, Ruppen M, Fawzi M, Ayral-Kaloustian S, Skotnicki J, Mansour T, Frost P, Gibbons J. PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors. Cancer Biol Ther. 2005;4:538-45.
4. Wu SY, Pan SL, Chen TH, Liao CH, Huang DY, Guh JH, Chang YL, Kuo SC, Lee FY, Teng CM. YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway. Br J Pharmacol. 2008;155:505-13.
5. Frey K, Schliemann C, Schwager K, Giavazzi R, Johannsen M, Neri D. The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinoma. J Urol. 2010;184:2540-8.
6. Lyons SK. Advances in imaging mouse tumour models in vivo. J Pathol. 2005;205:194-205.
7. Bromwich EJ, McArdle PA, Canna K, McMillan DC, McNicol AM, Brown M, Aitchison M. The relationship between Tlymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer. 2003;89:1906-8.
8. Monks A, Scudiero DA, Johnson GS, Paull KD, Sausville EA. The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anticancer Drug Des. 1997;12:533-41.
9. Pfister TD, ReinholdWC, Agama K, Gupta S, Khin SA, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH, Pommier Y. Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Mol Cancer Ther. 2009;8:1878-84.
10. Kobayashi M, Murakami T, Uchibori R, Chun NA, Kobayashi E, Morita T, Ozawa K. Establishment and characterization of transplantable, luminescence labeled rat renal cell carcinoma cell lines. J Urol. 2010;183:2029-35.
11. Kobayashi M, Okada T, Murakami T, Ozawa K, Kobayashi E, Morita T. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems. Urology. 2007;70:1230-6.
12. Naito S, von Eschenbach AC, Giavazzi R, Fidler IJ. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 1986;46:4109-15.
13. Fidler IJ, Naito S, Pathak S. Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice [corrected]. Cancer Metastasis Rev. 1990;9:149-65.
14. Rusciano D, Burger MM. Why do cancer cells metastasize into particular organs? Bioessays. 1992;14:185-94.
15. Welch DR. Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis. 1997;15:272-306.
16. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. Immunol. 1995;154:180-91.
17. Parthenais E, Haskill S. Immunity to the T1699 murine mammary tumor. II. Thymic influence on the in situ inflammatory response, metastatic growth and invasiveness. J Immunol. 1979;123:1334-8.
18. Pitelka DR, Hamamoto ST, Taggart BN. Epithelial cell junctions in primary and metastatic mammary tumors of mice. Cancer Res. 1980;40:1588-99.
19. Fidler IJ. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother Pharmacol. 1999;43(Suppl):S3-10.
20. Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer. 2006;5:56.
21. Hillman GG, Droz JP, Haas GP. Experimental animal models for the study of therapeutic approaches in renal cell carcinoma. In Vivo. 1994;8:77-80.